Chronic Myeloid Leukemia
Showing NaN - NaN of 31
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, MDS Trial in Houston (CliniMACS)
Not yet recruiting
- Acute Lymphoblastic Leukemia in Remission
- +10 more
- CliniMACS
-
Houston, Texas
- +1 more
Dec 8, 2022
Myeloid Malignancies, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Cyclophosphamide, Mesna, Filgrastim)
Recruiting
- Myeloid Malignancies
- +3 more
- Cyclophosphamide
- +7 more
-
Houston, TexasM D Anderson Caner Center
Nov 17, 2022
Chronic Myeloid Leukemia, Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission, Chronic Myeloid Leukemia in Remission Trial
Recruiting
- Chronic Myeloid Leukemia
- +2 more
- Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Withdrawal
- Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Re-initiation
-
Houston, Texas
- +3 more
Jan 25, 2022
Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))
Completed
- Chronic Myelomonocytic Leukemia
- +4 more
- Imatinib Mesylate (Gleevec)
-
Houston, TexasUT MD Anderson Cancer Center
Dec 7, 2021
Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)
Completed
- Chronic Myeloid Leukemia
- Omacetaxine mepesuccinate
-
Los Angeles, California
- +28 more
Dec 1, 2021
Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)
Completed
- Chronic Myeloid Leukemia
- Omacetaxine mepesuccinate
-
Los Angeles, California
- +31 more
Nov 11, 2021
Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)
Terminated
- Chronic Myeloid Leukemia
- Omacetaxine mepesuccinate
-
Jacksonville, Florida
- +9 more
Nov 6, 2021
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myeloid Leukemia Trial in Houston (Clofarabine, Busulfan, Fludarabine)
Completed
- Acute Myeloid Leukemia
- +2 more
- Clofarabine
- +5 more
-
Houston, TexasUT MD Anderson Cancer Center
Jan 6, 2021
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myeloid Leukemia Trial in Houston (Clofarabine 40mg/m^2, Idarubicin
Completed
- Acute Myeloid Leukemia
- +2 more
- Clofarabine 40mg/m^2
- +5 more
-
Houston, TexasUT MD Anderson Cancer Center
Dec 3, 2020
Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Houston (Fludarabine monophosphate, Busulfan, Stem Cell
Active, not recruiting
- Leukemia
- +9 more
- Fludarabine monophosphate
- +5 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 2, 2020
Chronic Myeloid Leukemia Trial in Worldwide (Dasatinib, Nivolumab)
Completed
- Chronic Myeloid Leukemia
-
Atlanta, Georgia
- +20 more
Mar 4, 2020
Chronic Myeloid Leukemia Trial in Worldwide (Bosutinib, imatinib)
Completed
- Chronic Myeloid Leukemia
-
Anaheim, California
- +165 more
Dec 19, 2018
Chronic Myeloid Leukemia (CML) in a Real-world Setting
Unknown status
- Chronic Myeloid Leukemia
- Non-Interventional
-
Muscle Shoals, Alabama
- +213 more
Jan 19, 2018
Acute Myeloid Leukemia, Chronic Myeloid Leukemia Trial in United States (PRI-724)
Completed
- Acute Myeloid Leukemia
- Chronic Myeloid Leukemia
-
Atlanta, Georgia
- +5 more
Aug 16, 2017
Acute Myelocytic Leukemia, Acute Lymphocytic Leukemia, Myeloproliferative Disease Trial in Houston (rigosertib)
Completed
- Acute Myelocytic Leukemia
- +3 more
-
Houston, TexasUniversity of Texas M. D. Anderson Cancer Center
Jun 22, 2017
Chronic Myeloid Leukemia Trial in Houston (Placebo, Armodafinil)
Terminated
- Chronic Myeloid Leukemia
- Placebo
- Armodafinil
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Nov 4, 2015
Chronic Myeloid Leukemia Trial in Houston (Peg Interferon Alpha 2b (Peg Intron), Ara-C (cytosine arabinoside))
Completed
- Chronic Myeloid Leukemia
- Peg Interferon Alpha 2b (Peg Intron)
- Ara-C (cytosine arabinoside)
-
Houston, TexasThe University of Texas M.D. Anderson Cancer Center
Nov 25, 2015
Chronic Myeloid Leukemia, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive Trial in United States (XL228)
Terminated
- Chronic Myeloid Leukemia
- Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
-
Los Angeles, California
- +5 more
Aug 19, 2015
Chronic Myeloid Leukemia Trial in Worldwide (ponatinib, imatinib (Gleevec/ Glivec))
Terminated
- Chronic Myeloid Leukemia
- ponatinib
- imatinib (Gleevec/ Glivec)
-
Burbank, California
- +169 more
Nov 5, 2014
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia Trial in Houston (Bendamustine)
Terminated
- Acute Myeloid Leukemia
- +3 more
-
Houston, TexasUT MD Anderson Cancer Center
Dec 3, 2012
Chronic Myeloid Leukemia, Minimal Residual Disease Trial in Houston (Synthetic Tumor-Specific Breakpoint Peptide Vaccine)
Completed
- Chronic Myeloid Leukemia
- Minimal Residual Disease
- Synthetic Tumor-Specific Breakpoint Peptide Vaccine
-
Houston, TexasUT MD Anderson Cancer Center
Aug 1, 2012